Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENFORCE trial of testosterone gel after radical prostatectomy
NL-OMON25840Not yet recruiting
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Hypoandrogenism (TD) and prostate cancer (PCa) comparing Testosterone gel with Placebo gel (2 arms). Primary endpoint: Sexual functioning at 12 months. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
testosterone
03
Conditions
Hypoandrogenism (TD)prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON25840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25840.